4//SEC Filing
PATEL DINESH V PH D 4
Accession 0001104659-25-021045
CIK 0001377121other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 8:02 PM ET
Size
7.2 KB
Accession
0001104659-25-021045
Insider Transaction Report
Form 4
PATEL DINESH V PH D
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-03-05$4.21/sh+24,000$101,040→ 564,260 total - Exercise/Conversion
Stock Option (right to buy)
2025-03-05−24,000→ 30,000 totalExercise: $4.21Exp: 2026-04-29→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]These stock options are fully vested.
Documents
Issuer
Protagonist Therapeutics, Inc
CIK 0001377121
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001120477
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 8:02 PM ET
- Size
- 7.2 KB